Novo Nordisk scientist Lotte Bjerre Knudsen paved the way for popular GLP-1 drugs like Ozempic.
AdvertisementInventor and scientist Lotte Bjerre Knudsen has spent her entire career at Novo Nordisk.
It's in recognition of the pivotal role she played in developing the first long-acting GLP-1 drugs.
Focus on what you knowPeptide therapies have taken off since the onset of the pandemic and the rise of weight loss drugs like Ozempic.
AdvertisementNow a chief science officer at Novo Nordisk, her executive role is far more focused on mentorship and governance than technical knowledge.
Persons:
Lotte Bjerre Knudsen, She's, Ozempic, she'd, they'd, she's, Lasker, Knudsen, Kinga Krzeminska, NurPhoto Knudsen, Michael Siluk, " Knudsen
Organizations:
Novo Nordisk, Novo Nordisk's, Kinga, Technical University of Denmark, Getty, Novo, Oxford University
Locations:
Copenhagen